Latest Earnings Analysis
-
AUNA (AUNA) Q3 2024: Mexico EBITDA Margin Jumps 4.7 Points as Platform Integration Accelerates
November 20, 2024 · AUNA
-
Ares Technology (AERT) Q2 2025: North America Up 13%, Non-Core Exit Drives Cost Reset
November 20, 2024 · AERT
-
ATAT Q3 2024: 72.8% Hotel Opening Surge Redefines Expansion Pace
November 19, 2024 · ATAT
-
Allot (ALLT) Q3 2024: Security Revenue Jumps 69% as Recurring Mix Reshapes Profit Path
November 19, 2024 · ALLT
-
Amerisports (AS) Q3 2024: Technical Apparel Surges 34%, Margin Expansion Accelerates Brand Investment
November 19, 2024 · AS
-
BellRing Brands (BRBR) Q4 2024: Premier Protein Drives 20% Sales Jump as Marketing Spend Ramps
November 19, 2024 · BRBR
-
AECOM (ACM) Q4 2024: Backlog Hits Record as 1.2x Book-to-Burn Fuels 10% Pipeline Growth
November 19, 2024 · ACM
-
Bit Digital (BTBT) Q3 2024: HPC Revenue Hits $12.2M, Accelerating Cloud Transformation
November 18, 2024 · BTBT
-
Brady (BRC) Q1 2025: Americas and Asia Drive 5.1% Organic Growth, Bolstering Niche Expansion Strategy
November 18, 2024 · BRC
-
Alibaba (BABA) Q2 2025: AI Cloud Revenue Soars Triple Digits, Driving 7% Segment Growth
November 15, 2024 · BABA
-
Beam Global (BEEM) Q3 2024: Commercial Mix Hits 48% as Product Suite and Global Expansion Diversify Revenue Base
November 15, 2024 · BEEM
-
Beneficent (BENF) Q2 2025: Permanent Equity Deficit Shrinks by $135M, Unlocking Capital Flexibility
November 15, 2024 · BENF
-
Antarex (ATEX) Q2 2025: $168M Contracted Proceeds and Accelerated Cash Drive Buyback Upside
November 14, 2024 · ATEX
-
Abiona Therapeutics (ABEO) Q3 2024: FDA Sets April PDUFA, Supply to Lag Demand at Launch
November 14, 2024 · ABEO
-
Ascendis Pharma (ASND) Q3 2024: Skytrofa Volume Up 60% as YorvaPath U.S. Launch Nears
November 14, 2024 · ASND
-
Bakkt (BKKT) Q3 2024: November Crypto Volume Surges 169% of October, Signaling Post-Election Tailwind
November 14, 2024 · BKKT
-
BrightView (BV) Q4 2024: EBITDA Margin Expands 110bps, Unlocking Balance Sheet Flexibility
November 14, 2024 · BV
-
AMCO Pittsburgh (AP) Q3 2024: Backlog Climbs $4.6M as Operational Upgrades Offset Volume Drag
November 14, 2024 · AP
-
BTAI Q3 2024: R&D Spending Down 74% as BXCL501 Pivotal Trials Advance
November 14, 2024 · BTAI
-
Applied Materials (AMAT) Q4 2024: Gate-All-Around Node Revenue Set to Double, Extending Technology Inflection Tailwind
November 14, 2024 · AMAT
-
AAP Q3 2024: 700 Store Closures Unlock $60–$80M Margin Tailwind as Turnaround Focus Intensifies
November 14, 2024 · AAP
-
Bilibili (BILI) Q3 2024: Games Revenue Jumps 84% as Platform Profitability Turns the Corner
November 14, 2024 · BILI
-
BK Technologies (BKTI) Q3 2024: Gross Margin Expands to 38.8% as EastWest Shift Unlocks Cost Leverage
November 14, 2024 · BKTI
-
Broadwind (BWEN) Q3 2024: Orders Surge 45% as Diversification Offsets Wind Pause
November 13, 2024 · BWEN
-
China Automotive Systems (CAAS) Q3 2024: EPS Sales Surge 44% as Market Share Gains Offset Margin Pressure
November 13, 2024 · CAAS
-
Arcos Dorados (ARCO) Q3 2024: Digital Channels Reach 58% of Sales, Powering Market Share Gains
November 13, 2024 · ARCO
-
Capricor (CAPR) Q3 2024: $1.5B Milestone Path as Daromyosel BLA Filing Targets 8,000-Patient Cardiac Market
November 13, 2024 · CAPR
-
Better Home & Finance (BETR) Q3 2024: HELOC Volume Surges 493% as Betsy AI Launch Reshapes Cost Structure
November 13, 2024 · BETR
-
AFCG Q3 2024: $116M Cannabis Loan Originations Signal Lending Dominance Amid Capital Scarcity
November 13, 2024 · AFCG
-
Alcon (ALC) Q3 2024: International ATIOL Growth Lifts Segment Share by 200 Basis Points
November 13, 2024 · ALC
-
BZH Q4 2024: Community Count Rises 20% as Spec Mix Drives Margin Compression
November 13, 2024 · BZH
-
Afya (AFYA) Q3 2024: Medical Student Base Climbs 12%, Margin Expansion Signals Operational Leverage
November 13, 2024 · AFYA
-
AYTU Q1 2025: Pediatric Revenue Jumps 54% as ADHD Baseline Scripts Expand
November 13, 2024 · AYTU
-
American Healthcare REIT (AHR) Q3 2024: Managed Segment Drives 17% NOI Growth, Pipeline Expands Beyond $1B
November 13, 2024 · AHR
-
CAE (CAE) Q2 2025: Defense Backlog Surges 94%, Reshaping Multi-Year Growth Visibility
November 13, 2024 · CAE
-
Camtek (CAMT) Q3 2024: HPC Drives 40% Revenue Surge as New Eagle G5 Orders Top $20M
November 12, 2024 · CAMT
-
Assured Guaranty (AGO) Q3 2024: $281M PVP Sets Fifth Consecutive Multi-Year High, Expanding Global Reach
November 12, 2024 · AGO
-
AbSci (ABSI) Q3 2024: $247M AstraZeneca Milestone Validates AI Platform, Internal Pipeline Targets H1 2025 Data
November 12, 2024 · ABSI
-
Azenta (AZTA) Q4 2024: Core Margin Expands 300bps as Portfolio Refocus Accelerates
November 12, 2024 · AZTA
-
BioT (BTMD) Q3 2024: Software Rollout Triggers 2.5 Point Headwind, Margin Expansion Holds
November 12, 2024 · BTMD
-
Acumen Pharmaceuticals (ABOS) Q3 2024: Altitude AD Enrollment Surges 75 Sites, Accelerating Phase 2 Momentum
November 12, 2024 · ABOS
-
Instacart (CART) Q3 2024: 39% EBITDA Surge Signals Tech Leverage and Omnichannel Expansion
November 12, 2024 · CART
-
ArchRock (AROC) Q3 2024: Electric Motor Drive Fleet Jumps to 544,000 HP, Margin Expansion Accelerates
November 12, 2024 · AROC
-
AstraZeneca (AZN) Q3 2024: U.S. Investment Rises $3.5B as Global Portfolio Drives 21% Growth
November 12, 2024 · AZN
-
AGEN Q3 2024: Cash Burn Drops 29% as BotVal Data Drives Strategic Asset Monetization
November 12, 2024 · AGEN
-
Axsome Therapeutics (AXSM) Q3 2024: Avelity Prescriptions Surge 108% as Pipeline Readouts Near
November 12, 2024 · AXSM
-
Acacia Research (ACTG) Q3 2024: Deflecto Adds $128M Revenue Platform, Expands Industrial Margin Base
November 12, 2024 · ACTG
-
Airgain (AIRG) Q3 2024: Consumer Segment Jumps $2M on Wi-Fi 7, Setting Stage for 2025 System Upside
November 12, 2024 · AIRG
-
BuzzFeed (BZFD) Q3 2024: Affiliate Commerce Surges 53%, Shifting Revenue Mix Toward High-Margin Engines
November 12, 2024 · BZFD
-
Blackstone Secured Lending (BXSL) Q3 2024: $956M Deployment Signals Super Cycle Positioning
November 12, 2024 · BXSL